Agile Therapeutics
AGRX
$1.51
Share price
0.00%
Change (1 day)
184.91%
Change (1 year)
Categories
Revenue for Agile Therapeutics (AGRX)
Revenue in 2024 (TTM): $21.56 Million USD
According to Agile Therapeutics
's latest financial reports the company's current revenue (TTM 
) is $21.56 Million USD. In 2023 the company made a revenue of $19.59 Million USD an increase over the revenue in the year 2022 that were of $10.88 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Agile Therapeutics from 2013 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | $21.56 M | 10.09% |
| 2023 | $19.59 M | 79.99% |
| 2022 | $10.88 M | 165.36% |
| 2021 | $4.1 M | 447.66% |
| 2020 | $0.74 M | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | $1.04 M | -95.17% | 🇺🇸 USA |
 | $0.18 B | 753.03% | 🇺🇸 USA |
 | $88.82 B | 411,718.43% | 🇺🇸 USA |
 | $64.16 B | 297,414.84% | 🇺🇸 USA |
 | $63.62 B | 294,901.85% | 🇺🇸 USA |